Chordia Therapeutics Inc.
No trades
No trades
Compare with Chordia Therapeutics Inc.
−20 JPY
−1.79 B JPY
0.00 JPY
34.06 M
Last report date
Jul 15, 2026
Report period
Q3 2026
EPS
−14.45 JPY
Profile
Sector
Industry
CEO
Hiroshi Miyake
Website
Headquarters
Fujisawa
Founded
2017
IPO date
Jun 14, 2024
ISIN
JP3283730004
FIGI
BBG01HTQQWW8
Identifiers
ISIN JP3283730004
Chordia Therapeutics, Inc. engages in the research and development of novel therapies for cancers. It handles research and development of low-molecular-weight drugs with unprecedented new mechanisms of action in the oncology area. The company was founded by Hiroshi Miyake and Daisuke Morishita on October 12, 2017 and is headquartered in Fujisawa, Japan.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Weight0.05%
Market value31.27 K
Explore more ETFs
Frequently asked questions
The current price of 190A is 77 JPY — it has decreased by −2.53% in the past 24 hours. Watch Chordia Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange Chordia Therapeutics Inc. stocks are traded under the ticker 190A.
190A stock has fallen by −3.75% compared to the previous week, the month change is a 4.05% rise, over the last year Chordia Therapeutics Inc. has showed a −60.91% decrease.
190A reached its all-time high on Aug 14, 2024 with the price of 930 JPY, and its all-time low was 66 JPY and was reached on Jun 18, 2026. View more price dynamics on 190A chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
190A stock is 5.26% volatile and has beta coefficient of 1.08. Track Chordia Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Chordia Therapeutics Inc. there?
Today Chordia Therapeutics Inc. has the market capitalization of 6.10 B, it has increased by 5.71% over the last week.
Yes, you can track Chordia Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Chordia Therapeutics Inc. is going to release the next earnings report on Oct 9, 2026. Keep track of upcoming events with our Earnings Calendar.
190A net income for the last quarter is −413.99 M JPY, while the quarter before that showed −338.38 M JPY of net income which accounts for 0.00% change. Track more Chordia Therapeutics Inc. financial stats to get the full picture.
No, 190A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 20, 2026, the company has 20 employees. See our rating of the largest employees — is Chordia Therapeutics Inc. on this list?
Like other stocks, 190A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Chordia Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Chordia Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Chordia Therapeutics Inc. stock shows the sell signal. See more of Chordia Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.